Education
About Us
Working with TipRanks
Follow Us
PaySign (PAYS)
NASDAQ:PAYS
Earnings Data
Report Date
Aug 12, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
0.03Last Year’s EPS
0.01Same Quarter Last Year
Strong Buy
Based on 5 Analysts Ratings
Earnings Call Summary
Earnings Call Date:May 08, 2025
|% Change Since: 32.10%
|Next Earnings Date:Aug 12, 2025
Earnings Call Sentiment|Positive
The earnings call reflected a strong quarter with record revenue growth, significant increases in net income and EBITDA, and exceptional performance in the Patient Affordability business. However, these positive outcomes were tempered by challenges in the plasma segment, which is experiencing revenue declines due to market surplus and efficiency improvements. Despite these challenges, the company's strategic acquisition of Gamma Innovation is expected to enhance future growth and operational efficiency.Company Guidance
In the first quarter of 2025, Paysign, Inc. reported impressive financial results with substantial year-over-year growth in several key metrics. Revenue increased by 41% to $18.6 million compared to $13.2 million in Q1 2024, while net income surged by 737% to $2.59 million. The company's adjusted EBITDA rose by 193% to $4.9 million, and the gross margin expanded over 10 points to 62.9%. The Patient Affordability segment showed exceptional performance with revenues up 261% to $8.6 million, processing claims growth of over 160%, and the addition of 14 new programs. However, the plasma donor compensation segment faced a 9.2% revenue decline, totaling $9.4 million, amid industry headwinds. Paysign's full-year 2025 guidance includes expected revenues between $72 million and $74 million, with net income projected at $6 million to $7 million. Adjusted EBITDA is anticipated to be in the range of $16 million to $17 million. The company forecasts Q2 2025 revenues between $18.5 million and $19 million, with gross profit margins of 63% to 64%.Record Revenue Growth
Revenue grew 41% year-over-year to $18.6 million, up from $13.2 million in Q1 of last year.
Significant Increase in Net Income
Net income surged to $2.59 million, a 737% increase over Q1 2024.
Adjusted EBITDA Growth
Adjusted EBITDA jumped 193% to $4.9 million.
Patient Affordability Business Success
Revenues rose 261% year-over-year to $8.6 million, with claims processed growing by more than 160%.
Gamma Acquisition Benefits
The acquisition is expected to add $4 million to $5 million in annual cash flow and has already shown promising operational efficiencies.
PAYS Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
PAYS Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 08, 2025 | $2.71 | $2.75 | +1.48% |
Mar 25, 2025 | $2.48 | $2.27 | -8.47% |
Nov 05, 2024 | $3.83 | $4.06 | +6.01% |
Jul 31, 2024 | $5.33 | $4.87 | -8.63% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does PaySign (PAYS) report earnings?
PaySign (PAYS) is schdueled to report earning on Aug 12, 2025, TBA Not Confirmed.
What is PaySign (PAYS) earnings time?
PaySign (PAYS) earnings time is at Aug 12, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is PAYS EPS forecast?
PAYS EPS forecast for the fiscal quarter 2025 (Q2) is 0.03.